Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShort-Term Debt issuances
Growth Metrics
Income Statement
Others
Ratios

Bristol Myers Squibb (BMYMP) Change in Inventory (2016 - 2025)

Bristol Myers Squibb (BMYMP) has disclosed Change in Inventory for 17 consecutive years, with -$71.0 million as the latest value for Q4 2025.

  • Quarterly Change in Inventory rose 59.43% to -$71.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $184.0 million through Dec 2025, down 62.14% year-over-year, with the annual reading at $184.0 million for FY2025, 62.14% down from the prior year.
  • Change in Inventory for Q4 2025 was -$71.0 million at Bristol Myers Squibb, down from $90.0 million in the prior quarter.
  • The five-year high for Change in Inventory was $282.0 million in Q1 2023, with the low at -$175.0 million in Q4 2024.
  • Average Change in Inventory over 5 years is $73.8 million, with a median of $28.5 million recorded in 2022.
  • The sharpest move saw Change in Inventory surged 28300.0% in 2023, then tumbled 188.83% in 2024.
  • Over 5 years, Change in Inventory stood at $128.0 million in 2021, then plummeted by 67.97% to $41.0 million in 2022, then skyrocketed by 380.49% to $197.0 million in 2023, then tumbled by 188.83% to -$175.0 million in 2024, then soared by 59.43% to -$71.0 million in 2025.
  • According to Business Quant data, Change in Inventory over the past three periods came in at -$71.0 million, $90.0 million, and -$4.0 million for Q4 2025, Q3 2025, and Q2 2025 respectively.